MedImmune, Inc. Deal is Seen as Plus for Maryland’s Biotech Industry

While some may have cringed at the news that home-grown biotech giant MedImmune was being acquired by AstraZeneca, officials are optimistic about what the deal means for Maryland’s bioscience industry.>>> Discuss This Story

MORE ON THIS TOPIC